Epilepsy drug vormatrigine moves to Long-Term safety check in 700 patients
NCT ID NCT07287163
First seen Dec 26, 2025 · Last updated May 15, 2026 · Updated 21 times
Summary
This study tests the long-term safety of the drug vormatrigine in adults with epilepsy who have already taken it in earlier studies. About 700 people will take the drug and be monitored for side effects like changes in temperature, heart rate, and blood pressure. The goal is to see if vormatrigine remains safe over time for controlling seizures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL SEIZURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Praxis Research Site
Miami Lakes, Florida, 33016, United States
-
Praxis Research Site
Naples, Florida, 34116, United States
-
Praxis Research Site
Lafayette, Louisiana, 70508, United States
-
Praxis Research Site
Bethesda, Maryland, 20817, United States
-
Praxis Research Site
Chesterfield, Missouri, 63005, United States
-
Praxis Research Site
Amherst, New York, 14226, United States
-
Praxis Research Site
Middletown, New York, 10941, United States
-
Praxis Research Site
El Paso, Texas, 79912, United States
-
Praxis Research Site
Houston, Texas, 77058, United States
-
Praxis Research Site
Bielefeld, 33617, Germany
-
Praxis Research Site
Tübingen, 72076, Germany
-
Praxis Research Site
Milan, 20133, Italy
-
Praxis Research Site
Pavia, 27100, Italy
-
Praxis Research Site
Bydgoszcz, 85163, Poland
-
Praxis Research Site
Katowice, 40123, Poland
-
Praxis Research Site
Barcelona, 08003, Spain
-
Praxis Research Site
Madrid, 28040, Spain
-
Praxis Research Site
Málaga, 29010, Spain
-
Praxis Research Site
Terrassa, 08222, Spain
-
Praxis Research Site
Valencia, 46026, Spain
Conditions
Explore the condition pages connected to this study.